We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PEG:NYSEPublic Service Enterprise Group Incorporated Analysis

Data as of 2026-03-10 - not real-time

$84.04

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Public Service Enterprise Group (PEG) trades around $84, notably below its DCF fair value of roughly $88, implying about a 7% upside. The stock benefits from a solid dividend yield of 3.19% and a payout ratio just under 60%, but free cash flow is negative and debt‑to‑equity is high at over 140, raising sustainability questions. Technicals show the price sitting between the 20‑day SMA ($84.81) and 50‑day SMA ($81.83) with a neutral trend, while the MACD histogram is negative and the signal line suggests bearish momentum. Recent earnings calls highlighted robust year‑end results, a dividend increase, and ambitious capital investment plans, especially in nuclear‑generated, emission‑free electricity. Volume is increasing, and the beta of 0.43 indicates low market sensitivity, though 30‑day volatility sits near 20%, reflecting moderate price swings. Overall, PEG appears modestly undervalued with growth characteristics, but the high leverage and cash‑flow gap temper confidence.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Price below DCF fair value offering near‑term upside
  • Technical support around $80 and increasing volume
  • Recent dividend increase reinforcing short‑term demand

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable regulated earnings offset by high leverage
  • Neutral technical indicators and modest growth outlook
  • Potential capital‑intensive projects may pressure cash flow

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Consistent dividend yield and regulated utility model
  • Strategic nuclear and solar investments supporting future cash flow
  • Low beta and defensive sector positioning for portfolio stability

Key Metrics & Analysis

Financial Health

Revenue Growth18.30%
Profit Margin17.35%
P/E Ratio19.9
ROE12.76%
ROA3.39%
Debt/Equity142.68
P/B Ratio2.5
Op. Cash Flow$3.3B
Free Cash Flow$-105000000
Industry P/E20.8

Technical Analysis

TrendNeutral
RSI51.9
Support$80.05
Resistance$87.63
MA 20$84.81
MA 50$81.83
MA 200$82.32
MACDBearish
VolumeIncreasing
Fear & Greed Index79.3

Valuation

Fair Value$87.97
Target Price$89.97
Upside/Downside7.06%
GradeUndervalued
TypeBlend
Dividend Yield3.19%

Risk Assessment

Beta0.43
Volatility20.45%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.